RecruitingNot ApplicableNCT06614959

The Effects of Oscillatory Positive Expiratory Pressure (OPEP) Therapy in Patients With COPD

Assessing the Effects of Oscillatory Positive Expiratory Pressure (OPEP) Therapy on Disease Impact and Respiratory System Dynamics in Patients With COPD: A Prospective Non-Pharmacologic Interventional Cohort Study


Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Enrollment

32 participants

Start Date

May 22, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this non-pharmacologic interventional study is to learn if Oscillatory Positive Expiratory Pressure (OPEP) therapy can improve disease impact and respiratory system dynamics in patients with COPD. The main questions it aims to answer are: Is OPEP therapy able to improve the impact of cough symptoms as measured on a validated symptom score? Is OPEP therapy able to improve the properties of the lung (called reactance) as measured by oscillometry? Researchers will compare the results of the same tests performed before and after 4 weeks of OPEP treatment to see if OPEP treatment improves cough symptoms and lung mechanics. * Participants with COPD will complete in-person baseline tests and will then receive the smart OPEP device. * These participants will then use the smart OPEP device at home, at least twice a day, for 4 consecutive weeks. * Finally, these participants will return to complete in-person end-of-study tests.


Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether oscillatory positive expiratory pressure (OPEP) therapy — a breathing technique using a small handheld device that creates vibrations to help clear mucus from the airways — can improve breathing and quality of life in people with COPD and chronic bronchitis. **You may be eligible if...** - You are 40 years old or older - You are a current or former smoker with at least a 10 pack-year smoking history - You have a confirmed diagnosis of COPD from a breathing test (spirometry) - You have chronic bronchitis, meaning you regularly cough up mucus or have a productive cough most days **You may NOT be eligible if...** - You have had a COPD flare-up (exacerbation) requiring hospitalization in the past 4 weeks - You have recently started or changed inhalers - You have other serious lung conditions such as active tuberculosis or severe asthma - You are already using OPEP therapy Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOscillatory Positive Expiratory Pressure (OPEP) Therapy

The smart OPEP device is a standard OPEP device equipped with an additional detachable sensor that collects diagnostic information on the total elapsed time of OPEP use, the pressure generated during use, frequency and amplitude of pressure oscillations, respiratory information (inhalations/exhalation number/time), and sum of all oscillations with a pressure over 1 centimeter of water (cmH2O), all of which will inform the duration and quality of home use.


Locations(1)

McGill University Health Centre

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06614959


Related Trials